It is a relationship that we are proud of. At the core of the relationship is sharing knowledge to improve outcomes for patients. We want to ensure that patients and others have confidence that this relationship is open and transparent and this is why the pharmaceutical industry is taking the lead on disclosing details of payments and other benefits in kind made by industry to HCPs and HCOs.
This information will be published on the database - Disclosure UK.
Disclosure UK is part of a Europe-wide initiative to increase transparency between pharmaceutical companies and the doctors, nurses, pharmacists and other health professionals and organisations it works with.
Please note: the Disclosure UK database does not currently work in Edge. Please search using Chrome, Internet Explorer, Firefox or Safari.
Disclosure update 22 April, 2020
During the COVID-19 pandemic, we want to minimise any further pressures on our NHS workers and organisations. We have held back certain modifications to the data currently published on Disclosure UK which would otherwise have triggered disclosure communications to those NHS workers at this time.
If you are a healthcare professional or healthcare organisation and have a question about published disclosure data, please log into the private disclosure portal and raise a query as normal. These queries will be resolved in the usual manner.
As well as searching Disclosure UK you can also download the full dataset and Methodological Notes to explore the data further.
Disclosure UK is an industry-led initiative to deliver a searchable database that shows payments and benefits in kind made by the pharmaceutical industry to doctors, nurses and other health professionals and organisations in the UK.
The resources on this page are available for use by the pharmaceutical industry, healthcare professionals (HCPs) and healthcare organisations (HCOs) to help them understand how Disclosure UK works.